Rehydra+ Wellness Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.6/10
Best for: low starting-tier subscription pricing, if you can confirm it covers your state
Rehydra+ Wellness scores highest on the strength of its clinical program — drug options and dosing support.
What the plan covers
Medication
Not disclosed
Provider visits
Not disclosed
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Rehydra+ Wellness is a San Antonio, Texas telehealth brand that grew out of a mobile IV therapy business run by paramedics and nurses. It sells compounded semaglutide and tirzepatide on tiered subscriptions that rise with dose, alongside testosterone therapy, NAD+, a lipotropic Lipo-Plus injection and a broad peptide catalogue including BPC-157, KPV, MOTS-C, tesamorelin, sermorelin and GHK-Cu. Consultations are free, prices are published on the storefront, and financed payment plans are offered. The company says it serves 20 states but does not list them.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Rehydra+ Wellness
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Rehydra+ Wellness at a glance
- Type
- GLP-1 telehealth provider
- Starting price
- $119/mo (Subscription dose ladder: Tier 1 $119, Tier 2 $169, Tier 3 $229 per month. One-time non-subscription vials start at $149; a separate 2.5 mg listing runs $399-$479.)
- Pricing model
- Scales with dose — higher doses cost more
- FDA status
- No FDA warning letter on record
How we scored Rehydra+ Wellness
Each dimension is scored algorithmically from Rehydra+ Wellness’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
5.7/10Rehydra+ Wellness does not post a standard monthly cash price up front, so cost transparency is limited — confirm the ongoing rate before you commit. Note the price scales with dose, so budget for higher tiers as you titrate.
Effectiveness25%
7.7/10Rehydra+ Wellness offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.2/10Online intake and platform experience — ongoing clinician messaging; 6 platform features disclosed.
Trust & Safety15%
6.6/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-08-07).
Accessibility10%
5.7/10Rehydra+ Wellness's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
6.0/10Clinician messaging between visits.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Rehydra+ Wellness review
Last checked August 2026- Confirmed current pricing across 2 dose/plan tiers
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with Rehydra+ Wellness
We walked Rehydra+ Wellness’s public signup flow in August 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Browse the storefront, where every product price is published without an account
- 2Complete a simple online intake form
- 3Get connected with a licensed provider through a third-party provider network for a remote appointment
- 4If approved, medication ships directly from a compounding pharmacy partner
- 5Subscriptions auto-renew and can be cancelled before the next billing date
- Prices for every product, including each subscription dose tier, are published on the public storefront with no gate.
- The consultation is advertised as free, and there is no membership fee layered on top of the medication price.
- The dose tiers are sold as separate products rather than one titrating plan, so the monthly cost rises as the dose steps up.
- Neither the compounding pharmacy nor the third-party provider network is named anywhere on the site.
- The About page states the company serves 20 states, but no list of those states is published.
GLP-1 medications Rehydra+ Wellness offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Peptides Rehydra+ Wellness offers
Beyond GLP-1s, Rehydra+ Wellness also offers these peptides — tap any for our evidence-based guide.
Pricing
Prices re-verified
Subscription dose ladder: Tier 1 $119, Tier 2 $169, Tier 3 $229 per month. One-time non-subscription vials start at $149; a separate 2.5 mg listing runs $399-$479.
Subscription dose ladder: Tier 1 $169, Tier 2 $289, Tier 3 $419 per month. One-time non-subscription vials start at $219.
Ready to get started?
Plans and promotions change often — check Rehydra+ Wellness's current pricing and active discounts before you decide.
What we like
- Tier 1 subscription pricing is genuinely low, at $119/mo semaglutide and $169/mo tirzepatide, below the compounded market median.
- Publishes a real phone and text line, (210) 560-0228, plus a named staff email, which many compounded-GLP-1 sites do not.
- Catalogue runs well beyond GLP-1: testosterone therapy, NAD+, and eight named peptides including BPC-157, KPV, MOTS-C and tesamorelin.
- Consultation is free and financed payment plans are offered, so the entry cost is low.
Watch-outs
- No legal entity is named anywhere; the Terms identify only the brand "Rehydra+", with no LLC or corporation behind it.
- Says it serves 20 states but never lists them, so you cannot confirm coverage before starting an intake.
- The LegitScript badge is a self-hosted image linking to the generic checker form; no certification record could be confirmed.
- All prescription sales are final once shipped, and neither the compounding pharmacy nor the provider network is named.
Is Rehydra+ Wellness worth it? Our verdict
Rehydra+ Wellness positions itself around one thing: low starting-tier subscription pricing, if you can confirm it covers your state.
On top of the prescription itself, Rehydra+ Wellness points to Subscription dose tiers, Peptides and TRT too, and Phone and text support.
How much Rehydra+ Wellness actually costs
Rehydra+ Wellness doesn't post a standard monthly cash price publicly. Start a consultation to get an exact quote, and confirm the ongoing rate — not just any first-month offer — before you commit.
Medications: what Rehydra+ Wellness prescribes
Rehydra+ Wellness prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy — the reason the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.
Who Rehydra+ Wellness is best for — and who should skip it
A good fit if you…
- value being able to message a clinician between visits.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
Rehydra+ Wellness offers clinician messaging between visits. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Rehydra+ Wellness could be worth a look, but it doesn't publish a standard price up front — get a quote and confirm the ongoing rate before deciding, and compare it against the alternatives below. If you're comparison-shopping, Sesame Care is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
Rehydra+ Wellness scores highest on the strength of its clinical program — drug options and dosing support.
Ready to start with Rehydra+ Wellness?
See current pricing and start your free consultation.
Rehydra+ Wellness might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Rehydra+ Wellness review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Rehydra+ Wellness's current pricing
Start your free consultation to check eligibility and today's price.